Rocket Lab Corporation (RKLB) traded at $63.93 at 9:52am UTC on 16 September 2026, within an intraday range of $61.79–$64.75. Past performance is not a reliable indicator of future results.
Trading followed Rocket Lab’s announcement that it had completed a $1.944bn at-the-market equity offering through 29.3 million shares to fund its pending acquisition of Iridium Communications. The company also terminated a $3.6bn bridge-financing commitment. The acquisition remains subject to regulatory approvals and is expected by Rocket Lab to close in mid-2027 (Rocket Lab, 15 September 2026).
Rocket Lab also completed its 16th Electron mission of 2026 on 11 September, taking the total number of Electron launches to 95 (Yahoo Finance, 11 September 2026).
Third-party RKLB outlook: Iridium funding, Neutron execution
As of 16 September 2026, third-party Rocket Lab stock predictions range from $80–$150, reflecting different assumptions around Neutron development, contract growth and the pending Iridium acquisition. These are third-party valuation estimates rather than expected outcomes.
Raymond James (individual price target)
Raymond James initiated coverage with an Outperform rating and an $80 target, around 29% above the roughly $62 share price cited at the time. Analyst Brian Gesuale pointed to Rocket Lab’s revenue growth and expanding launch cadence (Yahoo Finance, 11 September 2026).
Berenberg Bank (individual price target)
Berenberg initiated coverage with a Buy rating and an $83 target. Analyst Michael Filatov cited the potential growth of the global space market and Rocket Lab’s vertically integrated launch and constellation model (Investing.com, 2 September 2026).
Bank of America (individual price target)
Bank of America cut its target to $110 from $115 while maintaining a Buy rating. The revision reflected near-term execution risk alongside a positive longer-term view of the space sector (MarketBeat, 1 September 2026).
Cantor Fitzgerald (individual price target)
Cantor Fitzgerald raised its target to $122 from $96 while maintaining an Overweight rating. The revision followed Rocket Lab’s second-quarter revenue of approximately $234.1m, a company record that exceeded consensus estimates (Investing.com, 2 September 2026).
Stifel (individual price target)
Stifel held the highest target in this selection at $150. Analyst Erik Rasmussen cited Rocket Lab’s growing backlog as a potential counterweight to uncertainty around rocket testing and development (24/7 Wall St., 8 September 2026).
Takeaway: The cited targets span $80–$150. All five sources reported positive ratings, but the range highlights different assumptions around Neutron execution, contracts, margins and long-term demand.
Predictions and third-party forecasts are inherently uncertain, as they cannot fully account for unexpected market developments. Past performance is not a reliable indicator of future results.
Rocket Lab upcoming and latest earnings
Rocket Lab reported second-quarter 2026 results on 10 August. Revenue reached a record $234.1m, up 62% year on year and 16.8% sequentially, including $189.5m from Space Systems.
GAAP gross margin reached 36.1%, above guidance of 33%–35%, while the GAAP net loss narrowed to $49.3m, or $0.08 per share, from $66.4m, or $0.13 per share, a year earlier. Adjusted EBITDA loss was $8.8m, compared with guidance for a $20m–$26m loss, while backlog stood at $2.36bn (Rocket Lab, 10 August 2026).
For the third quarter, Rocket Lab published guidance for revenue of $250m–$265m, GAAP gross margin of 29%–31% and non-GAAP gross margin of 35%–37%. It also expects an adjusted EBITDA loss of $17m–$23m, GAAP operating expenses of $143m–$149m and non-GAAP operating expenses of $121m–$127m.
As of 16 September 2026, Rocket Lab’s investor-relations calendar doesn’t list a date for third-quarter results.
Rocket Lab stock price: technical overview
The RKLB stock price traded at $63.93 at 9:52am UTC on 16 September 2026, above its 10-day simple moving average near $63 but below its 20-, 50-, 100- and 200-day averages near $67, $71, $89 and $80 respectively.
The 14-day relative strength index stood at 39.79, below the 50 midpoint but above the conventional 30 oversold threshold. The average directional index was 21.17, below the 25 level often associated with an established trend. MACD at −3.36 and momentum at −0.37 were also negative, although these indicators don’t predict future direction on their own.
Higher technical references included the central pivot at $70.97 and R1 at $79.78, which sits close to the 200-day simple moving average area. Below the quoted price, the Hull moving average stood near $62.42, close to the intraday low of $61.79, while S1 at $55.12 provided a lower reference (TradingView, 16 September 2026).
These levels are technical reference points rather than indications of where RKLB will move next.
This is technical analysis for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any instrument.
RKLB share price history (2024–2026)
RKLB’s stock price traded near $7.19 on 17 September 2024 before rising through the final quarter. The stock moved from $9.25 at the start of October to $27.30 on 29 November, ending 2024 at $25.48.
In early 2025, RKLB moved mostly between $17–$31, closing at $30.38 on 24 January before falling to $17.14 on 10 March. The shares later recovered from $16.41 on 4 April to $30.08 on 20 June, before reaching $77.57 on 22 December.
RKLB began 2026 at $76.05 and fell to $57.44 on 30 March before rallying to a two-year high of $150.28 on 27 May. It traded above $100 during parts of June before retreating over the following months.
As of 9:52am UTC on 16 September 2026, RKLB traded near $63.93. The quoted level was around 11.0% below the $71.87 close a year earlier, while remaining well above its September 2024 level.
